Skip to main content
Top
Published in: Journal of Neurology 5/2020

01-05-2020 | Epstein-Barr Virus | Original Communication

Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape

Authors: Patrick B. Moloney, Siobhan Hutchinson, Joseph Heskin, Fiona Mulcahy, Yvonne Langan, Niall P. Conlon, Benjamin P. Linas, Courtney Takahashi, Anna M. Cervantes-Arslanian

Published in: Journal of Neurology | Issue 5/2020

Login to get access

Abstract

Discordant elevations of cerebrospinal fluid (CSF) human immunodeficiency virus (HIV) ribonucleic acid (RNA) in chronically treated patients known as ‘CSF escape’ may present as acute encephalitis. Infectious encephalitis caused by herpes simplex virus (HSV) and other neurotropic viruses have been identified as potential triggers of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Autoantibody-mediated encephalitis has been infrequently reported in HIV infected patients and may mimic HIV encephalitis. We report two adults infected with HIV presenting with encephalopathy and seizures. Case 1 had a monophasic encephalopathy with detection of NMDAR antibodies in the context of HIV CSF escape. There was a clinical response to immunotherapy and anti-retroviral therapy adjustment. Case 2 initially presented in non-convulsive status epilepticus associated with HIV CSF escape. He responded to treatment with anti-epileptic drugs and anti-retroviral therapy alteration, but had two further neurological relapses. NMDAR antibodies were detected during the relapses and a clinical response was observed following treatment with immunotherapy. Clinicians should consider autoimmune encephalitis in HIV infected patients presenting with encephalopathy and seizures, particularly in cases with concomitant HIV CSF escape.
Literature
1.
go back to reference Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S (2012) Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well-controlled plasma viral load. AIDS 26(14):1765–1774CrossRef Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S (2012) Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well-controlled plasma viral load. AIDS 26(14):1765–1774CrossRef
2.
go back to reference Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D (2017) Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J Acquir Immune Defic Syndr 75:246–255CrossRef Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D (2017) Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J Acquir Immune Defic Syndr 75:246–255CrossRef
3.
go back to reference Anguizola-Tamayo D, Bocos-Portillo J, Pardina-Viella L, Rodriguez-Sainz A, Vicente-Olabarria I, Martínez E, Gomez-Beldarrain M, Garcia-Monco JC (2019) Psychosis of dual origin in HIV infection: viral escape syndrome and autoimmune encephalitis. Neurol Clin Pract 9(2):178–180CrossRef Anguizola-Tamayo D, Bocos-Portillo J, Pardina-Viella L, Rodriguez-Sainz A, Vicente-Olabarria I, Martínez E, Gomez-Beldarrain M, Garcia-Monco JC (2019) Psychosis of dual origin in HIV infection: viral escape syndrome and autoimmune encephalitis. Neurol Clin Pract 9(2):178–180CrossRef
4.
go back to reference Haneche F, Demeret S, Psimaras D, Katlama C, Pourcher V (2018) An anti-NMDA receptor encephalitis mimicking an HIV encephalitis. Clin Immunol 193:10–11CrossRef Haneche F, Demeret S, Psimaras D, Katlama C, Pourcher V (2018) An anti-NMDA receptor encephalitis mimicking an HIV encephalitis. Clin Immunol 193:10–11CrossRef
5.
go back to reference Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772CrossRef Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772CrossRef
6.
go back to reference Armangue T, Leypoldt F, Malaga I et al (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317–323CrossRef Armangue T, Leypoldt F, Malaga I et al (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 75:317–323CrossRef
7.
go back to reference Armangue T, Moris G, Cantarin-Extremera V et al (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1736–1743CrossRef Armangue T, Moris G, Cantarin-Extremera V et al (2015) Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85:1736–1743CrossRef
8.
go back to reference DeSena A, Graves D, Warnack W, Greenberg BM (2014) Herpes simplex encephalitis as a potential cause of anti–N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol 71(3):344–346CrossRef DeSena A, Graves D, Warnack W, Greenberg BM (2014) Herpes simplex encephalitis as a potential cause of anti–N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases. JAMA Neurol 71(3):344–346CrossRef
9.
go back to reference Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, Frigo AC, Toldo I, Dale RC, Sartori S (2017) Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 59:796–805CrossRef Nosadini M, Mohammad SS, Corazza F, Ruga EM, Kothur K, Perilongo G, Frigo AC, Toldo I, Dale RC, Sartori S (2017) Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 59:796–805CrossRef
10.
go back to reference Salovin A, Glanzman J, Roslin K, Armangue T, Lynch DR, Panzer JA (2018) Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol Neuroimmunol Neurinflamm 5(4):e458CrossRef Salovin A, Glanzman J, Roslin K, Armangue T, Lynch DR, Panzer JA (2018) Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection. Neurol Neuroimmunol Neurinflamm 5(4):e458CrossRef
11.
go back to reference Prüss H, Finke C, Holtje M et al (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902–911CrossRef Prüss H, Finke C, Holtje M et al (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 72:902–911CrossRef
12.
go back to reference Schäbitz WR, Rogalewski A, Hagemeister C, Bien CG (2014) VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 83:2309–2311CrossRef Schäbitz WR, Rogalewski A, Hagemeister C, Bien CG (2014) VZV brainstem encephalitis triggers NMDA receptor immunoreaction. Neurology 83:2309–2311CrossRef
13.
go back to reference Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A (2016) CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm 3(4):e245CrossRef Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A (2016) CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm 3(4):e245CrossRef
14.
go back to reference Bundell C, Brunt SJ, Cysique LA, Brusch A, Brew BJ, Price P (2018) The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy. Pathology 50(3):313–316CrossRef Bundell C, Brunt SJ, Cysique LA, Brusch A, Brew BJ, Price P (2018) The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy. Pathology 50(3):313–316CrossRef
15.
go back to reference Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef
16.
go back to reference Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LE (1997) Clinical implications of autoantibodies in HIV infection. AIDS 11(15):1845–1850CrossRef Massabki PS, Accetturi C, Nishie IA, da Silva NP, Sato EI, Andrade LE (1997) Clinical implications of autoantibodies in HIV infection. AIDS 11(15):1845–1850CrossRef
17.
go back to reference Zandi MS, Paterson RW, Ellul MA, Jacobson L et al (2015) Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. J Neurol Neurosurg Psychiatr 86:708–713CrossRef Zandi MS, Paterson RW, Ellul MA, Jacobson L et al (2015) Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes. J Neurol Neurosurg Psychiatr 86:708–713CrossRef
18.
go back to reference King JE, Eugenin EA, Hazleton JE, Morgello S, Berman JW (2010) Mechanisms of HIV-tat-induced phosphorylation of anti–N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for NeuroAIDS pathogenesis. Am J Pathol 176:2819–2830CrossRef King JE, Eugenin EA, Hazleton JE, Morgello S, Berman JW (2010) Mechanisms of HIV-tat-induced phosphorylation of anti–N-methyl-D-aspartate receptor subunit 2A in human primary neurons: implications for NeuroAIDS pathogenesis. Am J Pathol 176:2819–2830CrossRef
Metadata
Title
Possible N-methyl-D-aspartate receptor antibody-mediated encephalitis in the setting of HIV cerebrospinal fluid escape
Authors
Patrick B. Moloney
Siobhan Hutchinson
Joseph Heskin
Fiona Mulcahy
Yvonne Langan
Niall P. Conlon
Benjamin P. Linas
Courtney Takahashi
Anna M. Cervantes-Arslanian
Publication date
01-05-2020
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 5/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09693-3

Other articles of this Issue 5/2020

Journal of Neurology 5/2020 Go to the issue